Immune Pharmaceuticals Inc.
Daniel Kazado is a Senior Advisor to Melini Capital, a family owned private and public equity firm investing internationally in several industries. Melini Capital has been an early and significant investor in Immune Pharmaceuticals. Daniel built his own management consulting firm over 15 years to 25 professionals advising boards of directors and senior management in multiple industries, and in 2002 sold the company to Altran Technologies, a global engineering and management consulting group with revenues of over 1 billion. Daniel earned a bachelor’s degree in Business Administration and a master’s degree in Management from Lyon University in France.